CYCLAINE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Cyclaine, and what generic alternatives are available?
Cyclaine is a drug marketed by Merck and is included in one NDA.
The generic ingredient in CYCLAINE is hexylcaine hydrochloride. Additional details are available on the hexylcaine hydrochloride profile page.
Summary for CYCLAINE
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 40 |
Patent Applications: | 2,188 |
DailyMed Link: | CYCLAINE at DailyMed |
US Patents and Regulatory Information for CYCLAINE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Merck | CYCLAINE | hexylcaine hydrochloride | SOLUTION;TOPICAL | 008472-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |